Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

BRIEF-Oncogenex Pharmaceuticals and Achieve Life Science announce definitive merger agreement

Published 2017-01-05, 04:58 p/m
Updated 2017-01-05, 05:00 p/m
© Reuters.  BRIEF-Oncogenex Pharmaceuticals and Achieve Life Science announce definitive merger agreement

© Reuters. BRIEF-Oncogenex Pharmaceuticals and Achieve Life Science announce definitive merger agreement

Jan 5 (Reuters) - Oncogenex Pharmaceuticals Inc OGXI.O

* Oncogenex Pharmaceuticals Inc and Achieve Life Science, Inc announce definitive merger agreement

* Oncogenex - upon completion of proposed merger, achieve's equity holders are expected to own 75 pct of combined company's outstanding shares

* Oncogenex Pharmaceuticals Inc - combined company's executive management team will be led by Rick Stewart, chairman of Achieve

* Oncogenex Pharmaceuticals - expected to distribute to its stockholders contingent value rights (CVRS) for 80 pct of any net proceeds of certain payments

* Oncogenex Pharmaceuticals Inc - board of directors of combined company is expected to consist of seven members

* Following completion of merger, Oncogenex Pharmaceuticals Inc ill be renamed Achieve Life Sciences Inc

* Oncogenex - after completion, current stockholders of oncogenex are expected to own remaining 25 pct of combined company's outstanding shares

* Oncogenex Pharmaceuticals Inc - "efforts will continue to establish a strategic partnership to further development of apatorsen"

* Oncogenex Pharmaceuticals Inc - transaction has been approved unanimously by boards of directors of both companies Source text for Eikon: ID:nCNWXDlcJa Further company coverage: OGXI.O

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.